This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Coronavirus Hits Feb Retail Sales: Winning & Losing ETFs
by Sanghamitra Saha
If February's grim retail sales report is any guide for March, then investors can easily get an idea about what lies ahead for these specific ETFs.
Colgate's (CL) 2.3% Dividend Hike Boosts Shareholder Value
by Zacks Equity Research
Colgate (CL) hikes quarterly cash dividend to 44 cents per share from 43 cents. Its efforts regarding product innovation and in-store implementation bode well.
Why Is Colgate-Palmolive (CL) Down 2.7% Since Last Earnings Report?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Colgate (CL) Gains From Growth Strategies, Cost Woes Persist
by Zacks Equity Research
Colgate (CL) is benefiting from innovation plans, savings program and expansion strategies. However, increased raw material costs, higher SG&A expenses and currency woes remain concerns.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
Church & Dwight (CHD) Q4 Earnings Meet Estimates, Sales Up
by Zacks Equity Research
Church & Dwight's (CHD) Q4 sales improve on benefits from category growth and market share gains. However, earnings decline year over year.
Colgate (CL) Stock Up on Q4 Sales Beat, Earnings In Line
by Zacks Equity Research
Colgate (CL) beats fourth-quarter 2019 sales estimates on strong volume and pricing gains. The company outlines view for 2020.
Income, Spending & Employment Cost Numbers, Plus More Q4
by Mark Vickery
Personal Income was lighter than expected last month, while Consumer Spending was in-line. Caterpillar, Exxon and Colgate all post Q4 results.
Colgate-Palmolive (CL) Meets Q4 Earnings Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0.00% and 1.85%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Colgate-Palmolive, Kellogg, The Hain Celestial Group and Post Holdings
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Colgate-Palmolive, Kellogg, The Hain Celestial Group and Post Holdings
Why Earnings Season Could Be Great for Colgate (CL)
by Zacks Equity Research
Colgate (CL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Things You Need to Know Before Clorox's (CLX) Q2 Earnings
by Sumit Singh
Clorox (CLX) has been witnessing operational headwinds in the Charcoal, and Bags and Wraps businesses, which have been hurting its Household segment, and in turn the top line for a while now.
Buy 4 Top Consumer Staples Stocks Ahead of Earnings Results
by Nalak Das
Fourth-quarter 2019 results have so far not been as disappointing as expected initially. However, overall earnings are still expected to dip.
Will Colgate (CL) Retain Its Positive Earnings Trend in Q4?
by Zacks Equity Research
Colgate's (CL) fourth-quarter 2019 results are likely to reflect benefits from its accelerated investment in brands, higher pricing, robust volume growth and strong innovation.
Colgate-Palmolive (CL) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Colgate to Buy Hello Brand, Expand Natural Products Line
by Zacks Equity Research
Colgate (CL) agrees to acquire Hello, a leading oral care brand in the United States. The deal is expected to close by February 2020.
Procter & Gamble (PG) Beats on Q2 Earnings, Down on Sales Miss
by Zacks Equity Research
Procter & Gamble's (PG) bottom line beats estimates in second-quarter fiscal 2020, while sales miss. Adjusted free cash flow productivity increases to 100%.
Colgate's (CL) Growth Initiatives On Track, Cost Woes Persist
by Zacks Equity Research
Colgate (CL) witnesses soft margins on increased raw material costs, higher SG&A expenses and currency woes. However, its innovation plans, savings program and expansion strategies might help.
Colgate Down 6% in 3 Months: Can Growth Efforts Revive Stock?
by Zacks Equity Research
Colgate (CL) is grappling with weak margins and adverse impacts of foreign currency. Nevertheless, its innovation plans, savings program and expansion strategies bode well.
The Zacks Analyst Blog Highlights: ExxonMobil, Starbucks, Diageo, Fidelity National Information Services and Colgate-Palmolive
by Zacks Equity Research
The Zacks Analyst Blog Highlights: ExxonMobil, Starbucks, Diageo, Fidelity National Information Services and Colgate-Palmolive
Top Stock Reports for ExxonMobil, Starbucks & Diageo
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including ExxonMobil (XOM), Starbucks (SBUX) and Diageo (DEO).
Stocks & ETFs to Profit From Cyber Monday Deals
by Sweta Killa
While investing in any of the retail stocks could reward investors throughout Cyber Week, a diverse approach in a basket form can also be a great choice.
Colgate-Palmolive (CL) Down 1.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Colgate-Palmolive (CL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Soap & Cleaning Materials Stock Outlook Buoyant on Innovation
by Rajani Lohia
The FMCG space gains from continued investment in brands, innovation, cost-containment and pricing actions. Escalating operating costs and unfavorable currency rates are headwinds.
Colgate (CL) Earnings Surpass Estimates in Q3, Sales Miss
by Zacks Equity Research
Colgate (CL) beats third-quarter 2019 earnings estimates on strong volume and pricing gains.